Individuals With a Family History of Colorectal Cancer Warrant Tailored Interventions to Address Patient-Reported Barriers to Screening.
Journal
Clinical and translational gastroenterology
ISSN: 2155-384X
Titre abrégé: Clin Transl Gastroenterol
Pays: United States
ID NLM: 101532142
Informations de publication
Date de publication:
01 05 2023
01 05 2023
Historique:
received:
16
08
2022
accepted:
01
03
2023
medline:
29
5
2023
pubmed:
21
3
2023
entrez:
20
3
2023
Statut:
epublish
Résumé
Population health interventions to increase colorectal cancer (CRC) screening rates often exclude individuals with a family history of CRC, and interventions to increase screening in this high-risk group are rare. We aimed to determine the screening rate and barriers and facilitators to screening in this population to inform interventions to increase screening participation. We performed a retrospective chart review and cross-sectional survey of patients excluded from mailed fecal immunochemical test (FIT) outreach because of a family history of CRC in a large health system. We used χ 2 , Fisher exact, and Student t tests to compare demographic and clinical characteristics of patients overdue and not overdue for screening. We then administered a survey (mailed and telephone) to overdue patients to assess barriers and facilitators to screening. There were 296 patients excluded from mailed FIT outreach, and 233 patients had a confirmed family history of CRC. Screening participation was low (21.9%), and there were no significant demographic or clinical differences between those overdue and not overdue for screening. There were 79 survey participants. Major patient-reported barriers to screening colonoscopy were patient forgetfulness (35.9%), fear of pain during colonoscopy (17.7%), and hesitancy about bowel preparation (29.4%). To facilitate screening colonoscopy, patients recommended reminders (56.3%), education about familial risk (50%), and colonoscopy education (35.9%). Patients with a family history of CRC who are excluded from mailed FIT outreach have low screening rates and report multiple mutable barriers to screening. They warrant targeted efforts to increase screening participation.
Identifiants
pubmed: 36940400
doi: 10.14309/ctg.0000000000000583
pii: 01720094-202305000-00001
pmc: PMC10208709
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e00583Informations de copyright
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology.
Références
Henrikson NB, Webber EM, Goddard KA, et al. Family history and the natural history of colorectal cancer: Systematic review. Genet Med 2015;17(9):702–12.
Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: Incidence, mortality, survival, and risk factors. Gastroenterol Rev 2019;14(2):89–103.
Lowery JT, Ahnen DJ, Schroy PC 3rd, et al. Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review [published correction appears in Cancer 2017;123(19):3857]. Cancer 2016;122(17):2633–45.
Tsai MH, Xirasagar S, Li YJ, et al. Colonoscopy screening among US adults aged 40 or older with a family history of colorectal cancer. Prev Chronic Dis 2015;12:140533.
Wilkinson AN, Lieberman D, Leontiadis GI, et al. Colorectal cancer screening for patients with a family history of colorectal cancer or adenomas. Can Fam Physician 2019;65(11):784–9.
Schoenfeld P. Evidence-based guidelines for screening individuals with a family history of colorectal cancer: More questions than answers. Gastroenterology 2018;155(5):1298–300.
Rex DK, Boland RC, Dominitz JA, et al. Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 2017;112(7):1016–30.
Wilkins T, McMechan D, Talukder A, et al. Colorectal cancer screening and surveillance in individuals at increased risk. Am Fam Physician 2018;97(2):111–6.
Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: Clinical guidelines and rationale: Update based on new evidence. Gastroenterology 2003;124(2):544–60.
Issaka RB, Avila P, Whitaker E, et al. Population health interventions to improve colorectal cancer screening by fecal immunochemical tests: A systematic review. Prev Med 2019;118:113–21.
Dougherty MK, Brenner AT, Crockett SD, et al. Evaluation of interventions intended to increase colorectal cancer screening rates in the United States: A systematic review and meta-analysis. JAMA Intern Med 2018;178(12):1645–58.
Hogan WR, Wagner MM. Accuracy of data in computer-based patient records. J Am Med Inform Assoc 1997;4(5):342–55.
Brown LJ, Roeger SL, Reed RL. Patient perspectives on colorectal cancer screening and the role of general practice. BMC Fam Pract 2019;20(1):109.
Yu C, Skootsky S, Grossman M, et al. A multi-level fit-based quality improvement initiative to improve colorectal cancer screening in a managed care population. Clin Transl Gastroenterol 2018;9(8):177.
Bakr O, Afsar-Manesh N, Raja N, et al. Application of behavioral economics principles improves participation in mailed outreach for colorectal cancer screening. Clin Transl Gastroenterol 2020;11(1):e00115.
Goshgarian G, Sorourdi C, May FP, et al. Effect of patient portal messaging before mailing fecal immunochemical test kit on colorectal cancer screening rates: A randomized clinical trial. JAMA Netw Open 2022;5(2):e2146863.
Rees G, Martin PR, Macrae FA. Screening participation in individuals with a family history of colorectal cancer: A review. Eur J Cancer Care 2008;17(3):221–32.
Ait Ouakrim D, Lockett T, Boussioutas A, et al. Screening participation predictors for people at familial risk of colorectal cancer: A systematic review. Am J Prev Med 2013;44(5):496–506.
Fletcher RH, Lobb R, Bauer MR, et al. Screening patients with a family history of colorectal cancer. J Gen Intern Med 2007;22(4):508–13.
Boonyasiriwat W, Hung M, Hon SD, et al. Intention to undergo colonoscopy screening among relatives of colorectal cancer cases: A theory-based model. Ann Behav Med 2014;47(3):280–91.
Bronner K, Mesters I, Weiss-Meilik A, et al. Determinants of adherence to screening by colonoscopy in individuals with a family history of colorectal cancer. Patient Educ Couns 2013;93(2):272–81.
Courtney RJ, Paul CL, Sanson-Fisher RW, et al. Individual- and provider-level factors associated with colorectal cancer screening in accordance with guideline recommendation: A community-level perspective across varying levels of risk. BMC Public Health 2013;13(1):248.
Gimeno Garcia AZ, Quintero E, Nicolas Perez D, et al. Colorectal cancer screening in first-degree relatives of colorectal cancer: Participation, knowledge, and barriers against screening. Eur J Gastroenterol Hepatol 2011;23(12):1165–71.
Australian Institute of Health and Welfare. National Bowel Cancer Screening Program: Monitoring Report 2018. AIHW: Canberra, 2018.
Honein-AbouHaidar GN, Kastner M, Vuong V, et al. Systematic review and meta-study synthesis of qualitative studies evaluating facilitators and barriers to participation in colorectal cancer screening. Cancer Epidemiol Biomarkers Prev 2016;25(6):907–17.
Wools A, Dapper EA, de Leeuw JR. Colorectal cancer screening participation: A systematic review. Eur J Public Health 2016;26(1):158–68.
Bobridge A, Price K, Gill TK, et al. Influencing cancer screening participation rates: Providing a combined cancer screening program (a ‘one stop’ shop) could be a potential answer. Front Oncol 2017;7:308.
Hall NJ, Rubin GP, Dobson C, et al. Attitudes and beliefs of non-participants in a population-based screening programme for colorectal cancer. Health Expect 2015;18(5):1645–57.
Levin TR, Jamieson L, Burley DA, et al. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev 2011;33(1):101–10.
Yoon PW, Scheuner MT, Peterson-Oehlke KL, et al. Can family history be used as a tool for public health and preventive medicine? Genet Med 2002;4(4):304–10.
Mehrabi S, Wang Y, Ihrke D, et al. Exploring gaps of family history documentation in EHR for precision medicine: A case study of familial hypercholesterolemia ascertainment. AMIA Jt Summits Transl Sci Proc 2016;2016:160–6.